Tyler Panzner
Tyler Panzner is a researcher who focuses on cell signaling models of disease and symptom triggers. His peer-reviewed research examines cellular mechanisms in breast cancer progression, including cell migration, invasion, and metastatic seeding. Additionally, his publications explore the properties and behavior of extracellular vesicles and exosomes in the context of HIV infection.
30 claims checked on air: 3 contradicted 6 overstated 20 supported 1 unverified
What they said on air
Low vitamin D is linked to autoimmunity, inflammation, and mental health conditions.
"We know that low vitamin D is linked to autoimmunity, inflammation, mental health conditions, you name it." (said at 0:03:14)
Extensive epidemiological and systematic review evidence demonstrates that low vitamin D status is consistently associated with autoimmune diseases, systemic inflammation, and mental health conditions (particularly depressive disorders). Meta-analyses of prospective and observational studies show increased risk of depression (odds ratio 1.45) and lower serum vitamin D concentrations in individuals with autoimmune disorders such as systemic lupus erythematosus and multiple sclerosis, alongside inverse relationships with inflammatory markers. While observational associations are robust, randomized trials investigating whether vitamin D supplementation causally reverses or prevents these conditions have yielded more mixed results.
Vitamin D receptor signaling stimulates brain cells to synthesize dopamine and serotonin.
"if it's a brain cell, it'll tell it to make more dopamine, make more serotonin. This is why seasonal depression exists." (said at 0:03:40)
Preclinical in vitro and in vivo studies demonstrate that active vitamin D (calcitriol) binds the vitamin D receptor (VDR) to stimulate the expression of the rate-limiting enzymes for both serotonin and dopamine synthesis in neuronal cells. Specifically, calcitriol upregulates tryptophan hydroxylase 2 (TPH2) transcription in brain cells via functional vitamin D response elements (VDREs) to enhance serotonin synthesis, and increases tyrosine hydroxylase (TH) expression to promote dopamine synthesis.
- supports: Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. (FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2014) · cited 416x in the literature
"Here, we present evidence that vitamin D hormone (calcitriol) activates the transcription of the serotonin-synthesizing gene tryptophan hydroxylase 2 (TPH2) in the brain at a vitamin D response element (VDRE)" (abstract, passage verified)
pubmedfull study (doi) - supports: 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin ge… (FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2015) · cited 177x in the literature
"Both VDREs bound the vitamin D receptor (VDR)-retinoid X receptor (RXR) complex and drove reporter gene transcription in response to 1,25-dihydroxyvitamin D3 (1,25D). Brain TPH2 mRNA, encoding the rate-limiting enzyme in serotonin synthesis, was induced 2.2-fold by 10 nM 1,25D in human U87 glioblastoma cells and 47.8-fold in rat serotonergic RN46A-B14 cells." (abstract, passage verified)
pubmedfull study (doi) - supports: Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. (Neuroscience 2015) · cited 132x in the literature
"Here we show that in VDR-expressing SH-SY5Y cells, 1,25(OH)2D3 significantly increased production of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis." (abstract, passage verified)
pubmedfull study (doi)
Vitamin D binding to immune cells shifts them away from a pro-inflammatory state.
"If it binds to an immune cell, it can quiet it down and shift away from a pro-inflammatory state." (said at 0:03:50)
The active form of vitamin D (1,25-dihydroxyvitamin D) binds to vitamin D receptors (VDR) present on numerous immune cell types (including T lymphocytes, B lymphocytes, macrophages, and dendritic cells). Activation of VDR signaling suppresses pro-inflammatory cytokine expression (such as IFN-gamma, IL-6, TNF-alpha, and IL-17) while promoting anti-inflammatory cytokine production (such as IL-10) and driving differentiation toward anti-inflammatory cell phenotypes (such as regulatory T cells and M2 macrophages).
- supports: 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cyt… (Journal of immunology (Baltimore, Md. : 1950) 2009) · cited 788x in the literature
"We observed that stimulation of CD4(+)CD25(-) T cells in the presence of 1,25(OH)(2)D(3) inhibited production of proinflammatory cytokines including IFN- gamma, IL-17, and IL-21 but did not substantially affect T cell division." (abstract, passage verified)
pubmedfull study (doi) - supports: Vitamin D: Nutrient, Hormone, and Immunomodulator. (Nutrients 2018) · cited 774x in the literature
"Vitamin D and VDR signaling together have a suppressive role on autoimmunity and an anti-inflammatory effect, promoting dendritic cell and regulatory T-cell differentiation and reducing T helper Th 17 cell response and inflammatory cytokines secretion." (abstract, passage verified)
pubmedfull study (doi) - supports: The Anti-Inflammatory Roles of Vitamin D for Improving Human Health. (Current issues in molecular biology 2024) · cited 104x in the literature
"Upon binding to VDRs, vitamin D (Vit D) regulates the expression of genes involved in immune responses, including those encoding for cytokines. It modulates the production of pro-inflammatory cytokines while promoting the synthesis of anti-inflammatory cytokines." (abstract, passage verified)
pubmedfull study (doi)
Vitamin D binding to osteoblasts stimulates bone formation.
"If it's an osteoblast or a bone cell, it stimulates the formation of bone. This is why it's linked to osteoporosis." (said at 0:03:56)
Active vitamin D (1α,25-dihydroxyvitamin D3) acts directly on bone cells through the vitamin D receptor (VDR) present in osteoblasts. Signaling via the VDR in osteoblasts regulates their differentiation into mature, bone-matrix-producing cells and controls extracellular matrix mineralization. In vitro and in vivo models confirm that vitamin D promotes osteoblast differentiation, stimulates the expression of bone matrix proteins, and facilitates bone formation and mineralization, which underpins its direct biological connection to bone density regulation and osteoporosis.
- supports: DKK1 Induced by 1,25D3 Is Required for the Mineralization of Osteoblasts. (Cells 2020) · cited 32x in the literature
"1α,25-dihydroxyvitamin D3 (1,25D3), the most popular drug for osteoporosis treatment, drives osteoblast differentiation and bone mineralization." (abstract, passage verified)
pubmedfull study (doi) - supports: Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts. (Nutrients 2023) · cited 78x in the literature
"During the bone formation process, osteoblasts undergo different stages which play a central role in the signaling pathways that are activated via the vitamin D receptor. Vitamin D is involved in directing the osteoblasts towards proliferation or apoptosis, regulates their differentiation to bone matrix producing cells, and controls the subsequent mineralization of the bone matrix." (abstract, passage verified)
pubmedfull study (doi) - supports: The role of Vitamin D as an adjunct for bone regeneration: A systematic review of literatu… (The Saudi dental journal 2023) · cited 27x in the literature
"Vit.D as an adjunct with stem cells and osteoblasts resulted in enhanced osteogenic differentiation and upregulation of genes coding for bone matrix proteins and alkaline phosphatase. When used in vivo, Vit.D resulted in early and increased new bone formation and mineralization within osseous defects" (abstract, results, passage verified)
pubmedfull study (doi)
Sleep deprivation increases the density of serotonin 2A (5-HT2A) receptors on the surface of the brain.
"sleep deprivation increases the amount of the serotonin 2A receptor on the surface of the brain. So that's actually the receptor that classical psychedelics bind to" (said at 0:11:43)
Human neuroimaging and animal studies show that acute sleep deprivation increases serotonin 2A (5-HT2A) receptor density and binding in the cerebral cortex. A PET imaging study in 18 healthy volunteers found that 24 hours of total sleep deprivation resulted in a 9.6% increase in neocortical [18F]altanserin binding at 5-HT2A receptors, with significant increases across several cortical areas including the frontal and parietal cortices. Rodent studies also demonstrate that 6 to 8 hours of sleep deprivation rapidly upregulates 5-HT2A receptor mRNA and protein levels in the frontal cortex via the transcription factor Egr3.
- supports: Sleep deprivation increases cerebral serotonin 2A receptor binding in humans. (Sleep 2012) · cited 76x in the literature
"A total of 24 hours of sleep deprivation led to a 9.6% increase of [(18)F]altanserin binding on neocortical 5-HT(2A) receptors. Significant region-specific increases were found in the medial inferior frontal gyrus, insula, and anterior cingulate, parietal, sensomotoric, and ventrolateral prefrontal cortices." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice v… (Molecular psychiatry 2022) · cited 23x in the literature
"Here, we show that a physiologic environmental stimulus, sleep deprivation, significantly upregulates 5-HT 2A R levels in the mouse frontal cortex in as little as 6-8 h (for mRNA and protein, respectively)." (abstract, results, passage verified)
pubmedfull study (doi)
Classical psychedelics, including psilocybin, LSD, DMT, and mescaline, produce their effects by binding to the serotonin 2A (5-HT2A) receptor.
"serotonin 2A receptor on the surface of the brain. So that's actually the receptor that classical psychedelics bind to and cause, you know, um psilocybin, LSD, DMT, mescaline." (said at 0:11:58)
Extensive pharmacological, preclinical, and human neuroimaging research establishes that classical psychedelics—such as psilocybin (via its active metabolite psilocin), LSD, DMT, and mescaline—exert their characteristic psychoactive and perceptual effects primarily through agonist or partial agonist activity at serotonin 5-HT2A receptors, particularly those located on cortical pyramidal neurons.
- supports: Psychedelics. (Pharmacological reviews 2016) · cited 1782x in the literature
"Today there is a consensus that psychedelics are agonists or partial agonists at brain serotonin 5-hydroxytryptamine 2A receptors, with particular importance on those expressed on apical dendrites of neocortical pyramidal cells in layer V." (abstract, description of mechanism, passage verified)
pubmedfull study (doi) - supports: Classical hallucinogens and neuroimaging: A systematic review of human studies: Hallucinog… (Neuroscience and biobehavioral reviews 2016) · cited 109x in the literature
"Serotonergic hallucinogens produce alterations of perceptions, mood, and cognition, and have anxiolytic, antidepressant, and antiaddictive properties. These drugs act as agonists of frontocortical 5-HT 2A receptors..." (abstract, background, passage verified)
pubmedfull study (doi)
Sleep-deprivation-induced hallucinations occur because the brain becomes hypersensitive to endogenous serotonin and DMT.
"when people start to hallucinate from sleep deprivation, you know, it's because they're literally getting hypersensitive to their brain's own serotonin and DMT." (said at 0:12:05)
Preclinical research in mice demonstrates that acute sleep deprivation can rapidly upregulate 5-HT2A serotonin receptors in the frontal cortex via the immediate early gene Egr3 (PMID: 35001075). However, attributing human sleep-deprivation hallucinations to the brain becoming hypersensitive to endogenous serotonin and DMT is an overstatement. There is no empirical evidence establishing that endogenous DMT plays a causative role in sleep-deprivation hallucinations or that receptor hypersensitivity to endogenous DMT drives psychotic symptoms in humans.
The CYP2R1 gene encodes the enzyme responsible for converting inactive supplemental vitamin D into calcifediol.
"turns out that gene, that CYP2R1 gene, and for you guys listening, a gene is instructions to make a protein. Think of a protein as a worker in the city, the city of you. The job of this protein is to take the inactive vitamin D, the form we supplement with, and turn it to the storage form that circulates in our bloodstream." (said at 0:16:29)
The CYP2R1 gene encodes cytochrome P450 family 2 subfamily R member 1, which functions as the principal hepatic microsomal vitamin D 25-hydroxylase. This enzyme converts parent vitamin D (cholecalciferol, the common supplemental and cutaneously synthesized form) into 25-hydroxyvitamin D (calcifediol / 25(OH)D), the primary circulating storage form of vitamin D in the bloodstream.
Rayaldee is a pre-activated vitamin D prescribed for multiple sclerosis.
"They prescribe that pre-activated vitamin D for multiple sclerosis. It's called Rayaldee." (said at 0:16:56)
Rayaldee is an extended-release formulation of calcifediol (25-hydroxyvitamin D3, a pro-hormone/intermediate metabolite). It is approved and prescribed for the treatment of secondary hyperparathyroidism in adult patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency, not for multiple sclerosis. Although calcifediol and vitamin D supplementation have been investigated experimentally in multiple sclerosis research trials, Rayaldee is neither indicated nor standardly prescribed for multiple sclerosis.
- context: Investigating the effects of 25-hydroxyvitamin D3 on clinical outcomes in multiple scleros… (Multiple sclerosis and related disorders 2024) · cited 1x in the literature
"While both groups showed an overall trend towards improved cognitive function at the end of the study, the calcifediol group exhibited greater improvements in most cognitive tests. However, the trial had no significant beneficial effects on MS relapse, EDSS score, quality of life, or fatigue in either group, the calcifediol or cholecalciferol." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: New insights into the management of secondary hyperparathyroidism in non-dialysis dependen… (Journal of nephrology 2026)
"This article examines the management of secondary hyperparathyroidism in non-dialysis dependent chronic kidney disease (NDD-CKD) patients in Switzerland, with a focus on optimizing bone and mineral health in CKD stages 3-4... A treatment algorithm incorporating extended-release calcifediol, as well as insights from KDIGO (Kidney Disease: Improving Global Outcomes) for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), are presented to refine therapeutic approaches." (abstract, passage verified)
pubmedfull study (doi)
In a 3-year clinical trial where humans took 10,000 IU of vitamin D daily without vitamin K2, participants developed no arterial calcification, and those with pre-existing calcification experienced no progression.
"We have clinical studies. They gave humans 10,000 IUs a day with no vitamin K2, which apparently should make you calcified. But they gave them 10,000 IUs every single day for 3 years. They measured their blood vessels, their arteries for calcification before and after 3 years. Not only did no one form any calcification, but the people that had existing calcification before the vitamin D had no more calcification." (said at 0:21:47)
The speaker refers to a 3-year randomized controlled trial (a secondary analysis of the Calgary Vitamin D Study) that evaluated 302 healthy adults randomized to 400, 4,000, or 10,000 IU of daily vitamin D3 without vitamin K2. The trial's findings partially support the claim but contradict the speaker's second assertion:
1. New calcification: Supported. High-resolution peripheral quantitative computed tomography (HR-pQCT) of the tibial artery showed that no participants without baseline calcification developed new arterial calcification over 3 years in any treatment arm.
2. Pre-existing calcification: Overstated/contradicted. Among the 85 participants with baseline tibial artery calcification, calcification quantity did not disappear or halt; it increased linearly over time at 0.020 mgHA/month (95% CI: 0.012 to 0.029). The 10,000 IU daily dose neither accelerated nor halted/reversed this progression compared to lower doses (p = 0.645 for group interaction).
Published case reports show that vitamin D toxicity requiring hospitalization occurs at blood levels of 200 to 250 ng/mL and above.
"there was a case report study that came out of someone kind of like that, but more severe. They were overdosing. Um they don't know the exact dosage, but they actually had some pretty major, you know, side effects, but they were off the chart. The highest the test could measure was 200, it was either 200 or 250 nanograms per milliliter... Had to get hospitalized for it." (said at 0:24:35)
Published case reports and endocrinology reviews corroborate that symptomatic vitamin D toxicity requiring acute medical management and hospitalization occurs with severe 25-hydroxyvitamin D elevations, with toxicity defined by concentrations above 150 ng/mL and severe clinical cases frequently exceeding standard assay upper limits (200 to 250 ng/mL).
Quercetin, resveratrol, and curcumin act as iron and copper chelators.
"All three of those are also iron and copper chelators." (said at 0:31:19)
Biochemical and pharmacological research confirms that quercetin, resveratrol, and curcumin possess metal-chelating properties, particularly toward redox-active transition metals such as iron (Fe) and copper (Cu). These polyphenols contain hydroxyl, catechol, or beta-diketone functional groups capable of forming coordination complexes with iron and copper ions, thereby helping suppress metal-mediated Fenton reactions and oxidative stress.
- supports: Management of oxidative stress and other pathologies in Alzheimer's disease. (Archives of toxicology 2019) · cited 304x in the literature
"The therapeutic potency of huperzine A and B, ginseng, curcumin and other compounds is manifested predominantly by the inhibitory action toward AChE, antioxidant or radical-scavenging and redox metal-chelating activity... Among the most promising group of substances with potential activity against AD are the flavonoids, including myricetin, morin, rutin, quercetin, fisetin, kaempferol, apigenin and glycitein, which have been shown, in vitro, to possess antiamyloidogenic and fibril-destabilization activity, as well as being able to act as metal chelators and to suppressing oxidative stress." (abstract, review text, passage verified)
pubmedfull study (doi)
Quercetin, resveratrol, and curcumin slow down the metabolic breakdown of neurotransmitters, including adrenaline.
"They also slow down the breakdown of neurotransmitters, including adrenaline." (said at 0:31:31)
Preclinical in vitro and animal studies demonstrate that quercetin, resveratrol, and curcumin can inhibit monoamine oxidase (MAO-A and MAO-B) and/or catechol-O-methyltransferase (COMT). These enzymes are the primary pathways responsible for the metabolic breakdown of monoamines and catecholamine neurotransmitters, including adrenaline (epinephrine), noradrenaline (norepinephrine), dopamine, and serotonin. However, because evidence is derived from enzyme assays and rodent models, in vivo translation in humans at standard dietary doses remains limited by bioavailability.
- supports: Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO… (Pharmacology 2003) · cited 56x in the literature
"Quercetin, a flavonoid present in many plants, is reported to inhibit COMT and MAO activities, the key enzymes involved in the metabolism of dopamine." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Antidepressant activity of curcumin: involvement of serotonin and dopamine system. (Psychopharmacology 2008) · cited 344x in the literature
"Curcumin (10-80 mg/kg, i.p.) dose dependently inhibited the immobility period, increased serotonin (5-hydroxytryptamine, 5-HT) as well as dopamine levels (at higher doses), and inhibited the monoamine oxidase enzymes (both MAO-A and MAO-B, higher doses) in mice." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Selectivity of Dietary Phenolics for Inhibition of Human Monoamine Oxidases A and B. (BioMed research international 2019) · cited 39x in the literature
"Monoamine oxidases (MAOs) regulate local levels of neurotransmitters such as dopamine, norepinephrine, and serotonin... curcumin, guaiacol, isoeugenol, pterostilbene, resveratrol, and zingerone were tested at their highest expected luminal concentrations from an oral dose. Each of these significantly inhibited both enzymes except for zingerone, which only inhibited MAO-A." (abstract, results)
pubmedfull study (doi)
Curcumin lowers dihydrotestosterone (DHT).
"what if it said boost neurotransmitters, can raise adrenaline, iron chelator, copper chelator, lowers DHT?" (said at 0:32:48)
Preclinical in vitro assays and cell culture models indicate that curcumin can inhibit 5α-reductase (the enzyme that converts testosterone to dihydrotestosterone) and decrease dihydrotestosterone (DHT) levels in cell models. However, there is a lack of robust human clinical trial evidence demonstrating that dietary or supplemental curcumin meaningfully lowers circulating DHT levels in humans.
Histamine, sulfites, glutamate, and adrenaline are excitatory to the brain and excite brain cells.
"Sulfur, or more specifically sulfites, glutamate, and adrenaline. Those are four that are all excitatory to the brain. They pump the gas. They rev up the brain and excite our brain cells." (said at 0:38:40)
Published neurobiological literature establishes that glutamate is the primary excitatory neurotransmitter in the mammalian central nervous system, and that histamine and adrenergic signaling (adrenaline/epinephrine and noradrenaline) act as central excitatory and arousal-promoting neuromodulators. Histamine directly increases neuronal excitability and depolarisation predominantly via H1 and H2 receptors, and positively modulates N-methyl-D-aspartate (NMDA) glutamate receptors, while adrenergic signaling similarly drives arousal and autonomic excitation.
Excess levels of histamine, sulfites, glutamate, and adrenaline are linked to anxiety.
"All four of those in excess levels are linked to anxiety." (said at 0:39:00)
Preclinical and clinical evidence links elevated levels or dysregulation of histamine, sulfites, glutamate, and adrenaline (noradrenergic signaling) to anxiety and anxiety-like behaviors. Preclinical rodent studies demonstrate that excessive sulfite intake induces anxiety-like behaviors, and elevated central histaminergic transmission potentiates stress-induced anxiety. In human psychiatric research, glutamatergic excitotoxicity and dysregulation of noradrenergic/adrenergic sympathetic stress pathways are recognized central mechanisms in anxiety disorders. The certainty is low due to primary reliance on animal models for sulfite-induced anxiety.
- supports: Efficacy of Curcumin in the Modulation of Anxiety Provoked by Sulfite, a Food Preservative… (Preventive nutrition and food science 2017) · cited 11x in the literature
"Exposure of sulfite in rats can induce anxiety, and curcumin can act as an anti-anxiety agent." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Histaminergic transmission potentiates post-traumatic stress-induced expression of anxiety… (Neuropharmacology 2025) · cited 5x in the literature
"Administration of histaminergic enhancing agents to SPS-exposed mice potentiated the higher expression of anxiety, also further enhanced CORT, and diminished the BDNF/CREB expression in all brain regions." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Nitric oxide plays a role in anxiety- and depression-like behaviors induced by sodium meta… (Toxicology letters 2025) · cited 1x in the literature
"Behavioral experiments demonstrated that sulfite exposure may cause anxiety- and depression-like behaviors, especially at 100 mg/kg and 260 mg/kg doses." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Neurotransmitter dysregulation in depression, anxiety, and suicidality: From synaptic dysf… (Psychiatry research 2026) · cited 4x in the literature
"Stress responses and neural circuits are disrupted by dysregulation of the serotonergic, noradrenergic, dopaminergic, GABAergic, and glutamatergic systems, which leads to oxidative stress, excitotoxicity, neuroinflammation, and decreased trophic support." (abstract, passage verified)
pubmedfull study (doi)
Histamine, glutamate, and sulfur dysregulation are linked to OCD, depression, ADHD, Tourette's syndrome, and autism spectrum disorder.
"if you look at histamine, glutamate, sulfur, it's also linked to OCD, depression, ADHD, Tourette's syndrome, autism spectrum disorder, so many different things." (said at 0:39:04)
Scientific literature extensively links dysregulation of neurotransmitter and metabolic pathways—specifically glutamate, histamine, and sulfur-related pathways (such as sulfur amino acid/transsulfuration metabolism and hydrogen sulfide signaling)—to neuropsychiatric and neurodevelopmental conditions including obsessive-compulsive disorder (OCD), depression, attention-deficit/hyperactivity disorder (ADHD), Tourette's syndrome, and autism spectrum disorder (ASD). Systematic reviews and neurobiological literature confirm alterations in central glutamatergic signaling and metabolite levels across pediatric and adult ADHD, ASD, OCD, and major depressive disorder (e.g., measured via magnetic resonance spectroscopy). Furthermore, genetic and neurochemical studies demonstrate the role of the histaminergic system (e.g., histidine decarboxylase mutations and receptor dysregulation) in the pathogenesis of Tourette's syndrome and OCD.
- supports: Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the… (The Journal of clinical psychiatry 2014) · cited 30x in the literature
"Most consistently, increases in glutamatergic metabolites were found in the anterior cingulate cortex (ACC) and other regions in youth with attention-deficit/hyperactivity disorder (ADHD). Limited data suggested increases in glutamatergic metabolites in youth with autism spectrum disorders, emotional dysregulation, and high risk for schizophrenia and decreases in youth with major depression, bipolar disorder, and obsessive-compulsive disorder." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Histamine, Neuroinflammation and Neurodevelopment: A Review. (Frontiers in neuroscience 2021) · cited 125x in the literature
"Indeed, a reduction in the synthesis of this neuromodulator has been associated with the disorders Tourette's syndrome and obsessive-compulsive disorder, with evidence that this may be through the disruption of the corticostriatal circuitry during development." (abstract, background, passage verified)
pubmedfull study (doi) - supports: The Histaminergic System in Neuropsychiatric Disorders. (Biomolecules 2021) · cited 56x in the literature
"Next, we comprehensively summarize recent experimental and clinical findings on the precise role of histaminergic system in neuropsychiatric disorders, including cell-type role and its circuit bases in narcolepsy, schizophrenia, Alzheimer's disease, Tourette's syndrome and Parkinson's disease." (abstract, results, passage verified)
pubmedfull study (doi)
A study showed that major psychiatric disorders share common genetic underpinnings and represent sub-clusters of the same genetic architecture.
"A new study came out that basically said every psychiatric disorder is pretty much sub-clusters of the same genetic underpinnings." (said at 0:39:30)
No published record matching the specific claim that a study showed psychiatric disorders are sub-clusters of the same shared genetic underpinnings was located in the retrieved records; this does not prove the claim false.
Exercise causes the release of histamine, which functions to dilate blood vessels for increased blood flow.
"Exercise releases histamine. And that's not necessarily a bad thing, but that's how we dilate our blood vessels to get more blood flow." (said at 0:40:20)
Human physiological studies and clinical trials show that exercise induces the release of histamine within skeletal muscle, which acts on histamine H1 and H2 receptors to produce sustained post-exercise vasodilation (hyperemia) and enhanced blood flow. Combined pharmacological blockade of H1 and H2 receptors suppresses post-exercise leg blood flow and vasodilation in both sedentary and endurance-trained individuals.
In a human study where participants were injected with liquid histamine, increasing histamine within the upper-normal range caused increased heart rate and anxiety as the first symptoms.
"They did a study: they injected humans with pure liquid histamine... What was the first symptom that showed up? If here's the range of normal histamine levels, even going from middle of normal to upper normal, that is still in the normal range, first thing that happened was increased heart rate and anxiety." (said at 0:41:20)
Human intravenous histamine infusion studies show that an increase in heart rate (tachycardia) is indeed the first objective physiological response to appear as plasma histamine rises, occurring at a lower concentration threshold than flushing, headache, or blood pressure changes. However, the claim overstates the details: achieving a 30% increase in heart rate required elevating plasma histamine above resting baseline levels (to ~1.61 ng/mL compared to a baseline of ~0.62 ng/mL), rather than remaining within the middle-to-upper normal range. Additionally, anxiety was not documented as a primary symptom or endpoint in these infusion protocols.
Supplemental glutamine can be converted in the body into both glutamate and ammonia.
"Glutamate: glutamine is the biggest mistake I see people make. It's recommended so often for the gut. Hey, does it help those enterocytes link together? Yes, it does. But that also can get converted into not just glutamate, but also ammonia as well, which can cause issues for people." (said at 0:43:25)
Glutamine catabolism in human physiology is mediated primarily by the enzyme glutaminase (such as GLS1 and GLS2), which hydrolyzes glutamine into glutamate and ammonia (ammonium ion). In reverse, glutamine synthetase ligates ammonia and glutamate to form glutamine. When supplemental or dietary glutamine is metabolized by enterocytes, the liver, kidneys, or the brain, glutaminase-mediated conversion into both glutamate and ammonia is a standard and well-characterized biochemical pathway.
Glutamine supports intestinal epithelial integrity by helping enterocytes link together.
"Glutamate: glutamine is the biggest mistake I see people make. It's recommended so often for the gut. Hey, does it help those enterocytes link together? Yes, it does." (said at 0:43:41)
Published experimental studies and reviews consistently show that glutamine plays a critical role in intestinal barrier function by promoting the expression, assembly, and localization of tight junction proteins (such as claudins, occludin, and zonula occludens proteins) that connect adjacent enterocytes, thereby reducing paracellular permeability.
- supports: L-Glutamine Enhances Tight Junction Integrity by Activating CaMK Kinase 2-AMP-Activated Pr… (The Journal of nutrition 2016) · cited 151x in the literature
"In addition, 2.0 mmol Gln/L increased (P < 0.05) the abundance of transmembrane proteins, such as occludin, claudin-4, junction adhesion molecule (JAM)-A, and the plaque proteins zonula occludens (ZO)-1, ZO-2, and ZO-3 by 1.8-6 times." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Glutamine and the regulation of intestinal permeability: from bench to bedside. (Current opinion in clinical nutrition and metabolic care 2017) · cited 80x in the literature
"Glutamine is a major nutrient to maintain intestinal barrier function in animals and humans. Depletion of glutamine results in villus atrophy, decreased expression of tight junction proteins and increased intestinal permeability. Moreover, glutamine supplementation can improve gut barrier function in several experimental conditions of injury and in some clinical situations." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Supplementation with Rhodiola rosea can raise adrenaline levels.
"Whether you're taking a quercetin supplement that raises adrenaline, or a Rhodiola rosea that can do that, or you're having tomatoes or vinaigrette for lunch, or you're having garlic, onions, or tomatoes for dinner." (said at 0:48:53)
Evidence that Rhodiola rosea supplementation increases circulating adrenaline (epinephrine) levels is lacking. In a randomized crossover trial evaluating short-term Rhodiola rosea supplementation (1500 mg/day) during resistance exercise, resting norepinephrine levels were higher compared to placebo, but epinephrine levels were not significantly different between conditions. Furthermore, preclinical studies generally describe Rhodiola rosea as an adaptogen with anti-adrenergic and cardioprotective actions that blunt excessive stress-induced catecholamine surges rather than stimulating adrenaline release.
Rising estrogen levels, such as during the days leading up to ovulation, cause histamine levels to increase.
"Now, what else can raise histamine? Estrogen can. So, work with a lot of women, and around ovulation, sure you know this, estrogen goes up, histamine follows up with it as well." (said at 0:52:05)
Preclinical and clinical evidence indicates that estrogen promotes mast cell activation and histamine release, and that allergic and mast-cell-mediated responses peak during the mid-cycle/ovulatory phase when estrogen levels are highest. In vitro and animal studies demonstrate that estradiol directly induces mast cell migration, maturation, and degranulation, leading to histamine release. In human studies of cycling women, mast cell reactivity and allergen skin-test responses show significant peaks at mid-cycle corresponding to peak estrogen concentrations.
- supports: Is the menstrual cycle affecting the skin prick test reactivity? (Asian Pacific journal of allergy and immunology 2004) · cited 24x in the literature
"Serum estradiol and LH levels showed positive correlation with SPT reactivity to allergens at mid-cycle. Our results suggest that SPT give the best results when they are performed at mid-cycle. Additionally, allergens seem to cause mast cell degranulation to a greater extent in subjects in which endogenous hormones like estradiol and LH are elevated." (abstract, results, passage verified)
pubmed - supports: Estradiol and progesterone regulate the migration of mast cells from the periphery to the … (PloS one 2010) · cited 149x in the literature
"By using a model of ovariectomized animals, we provide clear evidences that also in vivo, estradiol and progesterone attract MC to the uterus and further provoke their maturation and degranulation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Gender-related effects of sex steroids on histamine release and FcεRI expression in rat pe… (Journal of immunology research 2015) · cited 55x in the literature
"Sex steroids, mainly estradiol and progesterone, have been demonstrated to elicit MCs activation. ... Our results demonstrated that effect of sex steroids on MCs histamine release is dose- and gender-dependent and can be direct, synergistic, or inhibitory depending on whether hormones are used alone or to pretreat MCs followed by substance P-stimulation or upon IgE-mediated stimulation." (abstract, results)
pubmedfull study (doi) - supports: Influence of the menstrual cycle on skin-prick test reactions to histamine, morphine and a… (Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1995) · cited 84x in the literature
"Results indicate a significant increase in weal-and-flare size to histamine, morphine, and parietaria on days 12-16 of the cycle, corresponding to ovulation and peak oestrogen levels." (abstract, results, passage verified)
pubmedfull study (doi)
Stress and adrenaline trigger the release of histamine.
"And we need to remember adrenaline, stress itself releases histamine, right?" (said at 0:59:30)
The claim states that adrenaline and stress trigger the release of histamine. While psychological and physiological stress can stimulate mast cell degranulation and histamine release via neuropeptides and neuroendocrine pathways (such as corticotropin-releasing hormone and substance P), adrenaline (epinephrine) does the opposite: it is a potent mast cell stabilizer that suppresses and inhibits histamine release via beta-2 adrenergic receptors. Because of this inhibitory action on mast cell mediator release and its physiological counter-effects, adrenaline is used as the first-line medical treatment for acute histamine-mediated allergic reactions and anaphylaxis.
- contradicts: beta2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused … (European journal of immunology 2005) · cited 38x in the literature
"beta2AR activation by epinephrine, norepinephrine, and salbutamol suppressed the IgE receptor-dependent release of histamine, lipid mediators, and TNF-alpha, and inhibited SCF-dependent MC proliferation and migration." (abstract, results, passage verified)
pubmedfull study (doi) - contradicts: Prazosin Potentiates Mast Cell-Stabilizing Property of Adrenaline. (Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2024) · cited 5x in the literature
"Adrenaline quickly inhibits the release of histamine from mast cells." (abstract, background, passage verified)
pubmedfull study (doi)
Histamine and glutamate signaling pathways are directly involved in the cell signaling of chronic pain.
"But first, we know that histamine and glutamate signaling and therefore sulfur signaling, these are linked to chronic pain. It's literally the cell signaling of pain." (said at 0:59:30)
Preclinical research demonstrates that both glutamate and histamine signaling pathways directly mediate nociception and neuroinflammation in chronic neuropathic and inflammatory pain. Glutamate serves as the primary excitatory neurotransmitter in primary afferent nociceptors and central spinal pain pathways, driving hyperalgesia via receptors such as NMDA subunit GluN2B. Histamine acts via H1-H4 receptors on sensory neurons and glial cells to modulate pain hypersensitivity and neuroimmune responses.
- supports: Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic I… (Frontiers in pharmacology 2022) · cited 3x in the literature
"Overall, our findings further emphasize the key role for histamine in the regulation of histaminergic itch and chronic neuropathic pain." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Histamine H 3 receptor blockade alleviates neuropathic pain through the regulation of glia… (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025) · cited 7x in the literature
"A promising target for developing new analgesics is histamine H 3 receptor (H 3 R)... E-98 attenuated nociceptive responses in a dose- and time-dependent manner, and this effect is correlated with reduced microglia and increased astroglia activation." (abstract, background and results)
pubmedfull study (doi) - supports: PTP1B in dorsal root ganglion nociceptors drives neuropathic pain via a presynaptic Src/Gl… (Regional anesthesia and pain medicine 2026)
"This led to enhanced phosphorylation of the NMDA receptor GluN2B subunit at Tyr1472, increasing presynaptic glutamate release in the spinal dorsal horn, as evidenced by elevated miniature excitatory postsynaptic currents." (abstract, results, passage verified)
pubmedfull study (doi)
A study found that individuals with chronic pain scored significantly higher in perfectionism and lower in self-compassion compared to control groups.
"Now this study came out that was linking perfectionism to chronic pain. So they scored people based on perfectionism for themselves, holding others to impossibly high standards. So they were very high in that, the chronic pain versus the control group. And then they had low self-compassion." (said at 0:59:50)
A 2025 publication evaluated perfectionism, self-compassion, and self-efficacy across two survey cohorts comparing adults with chronic pain to pain-free controls (Study 1: n = 237 with chronic pain vs. n = 237 controls; Study 2: n = 294 with chronic pain vs. n = 278 controls). Across both cohorts, individuals experiencing chronic pain scored significantly higher on measures of perfectionism (specifically socially prescribed perfectionism in Study 1, and overall perfectionism in Study 2) and significantly lower in self-compassion compared to control groups without pain. Because the evidence relies on cross-sectional self-report surveys, the certainty of evidence is low.
Genetic variants in glutamate signaling pathways are linked to chronic pain.
"So we know genetic variants in glutamate signaling are linked to chronic pain." (said at 1:00:35)
Large-scale genome-wide association studies (GWAS) and functional genomic analyses have demonstrated that genetic variants associated with chronic pain risk are significantly enriched in glutamatergic pathways and excitatory glutamatergic neurons. In a meta-analysis of over 1.2 million individuals integrated with human dorsal root ganglia and brain single-cell transcriptomics, pain-associated genetic loci and heritability were strongly enriched in central glutamatergic neurons and peripheral sensory neurons with pathways implicated in glutamatergic signaling. Additionally, specific polymorphisms in genes regulating glutamatergic receptor trafficking (such as CACNG2/stargazin, which regulates AMPA receptor trafficking) have been linked to human chronic pain susceptibility.
- supports: Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. (Genome research 2010) · cited 141x in the literature
"CACNG2 encodes for stargazin, a protein intimately involved in the trafficking of glutamatergic AMPA receptors... Finally, we showed that human CACNG2 polymorphisms are associated with chronic pain in a cohort of cancer patients who underwent breast surgery." (abstract, results)
pubmedfull study (doi) - supports: The cell-type-specific genetic architecture of chronic pain in brain and dorsal root gangl… (The Journal of clinical investigation 2025) · cited 4x in the literature
"Pain-associated variants were enriched in glutamatergic neurons, mainly in the prefrontal cortex, hippocampal CA1-3, and amygdala... In hDRG, implicated genes were related to glutamatergic signaling and neuronal projection." (abstract, results)
pubmedfull study (doi) - supports: A high-resolution genomic roadmap for chronic pain converges on glutamatergic neurons and … (The Journal of clinical investigation 2025) · cited 1x in the literature
"Genetic risk was predominantly enriched in central glutamatergic neurons, particularly those in the prefrontal cortex, hippocampus, and amygdala." (abstract, results, passage verified)
pubmedfull study (doi)
Studies of traditional African tribes show natural vitamin D levels over 150 ng/mL.
"there were studies of tribes in Africa, their natural levels I think are over 150 nanograms per milliliter, right? And naked in the sun." (said at 1:03:00)
Studies measuring serum 25-hydroxyvitamin D concentrations in traditionally living East African populations (such as the Maasai pastoralists and Hadzabe hunter-gatherers) report average levels of approximately 115 nmol/L (~46 ng/mL), with individual values ranging from 58 to 171 nmol/L (~23 to 68 ng/mL). The speaker appears to have confused nmol/L with ng/mL; natural levels are well below 150 ng/mL (which would equal ~375 nmol/L, a level associated with vitamin D toxicity).
One-third of people are hyper-responders to saturated fat, causing their LDL levels to spike significantly and potentially leading to weight gain.
"Red meat is highly nutritious, but one-third of people are hyper-responders to saturated fat, so their LDL goes through the roof. It could be linked to more weight gain." (said at 1:09:20)
The speaker conflates several concepts regarding dietary lipid responses. In nutritional science, the concept of 'hyper-responders' most commonly refers to dietary cholesterol challenges (such as egg feeding studies), where approximately 25% of individuals experience more pronounced increases in plasma cholesterol (both LDL-C and HDL-C), while roughly 75% show little to no response. When evaluated in randomized dietary trials altering saturated versus polyunsaturated fat intake, cholesterol response follows a continuous, graded distribution rather than defining a discrete one-third subpopulation of 'hyper-responders.' Furthermore, there is no robust evidence establishing that saturated-fat-induced LDL hyper-responsiveness is directly linked to increased weight gain.
Fact-checked episodes
Publications